Workflow for removal of dislodged leadless pacemaker from distal pulmonary artery: A case report

HeartRhythm Case Reports 2026 Open access

Read full text
Authors: Muhammad Taimur, Mohammed M. Shaheriyar, Farman Ali, Eraj Sabeeh, Abdullah Naseer, Sohail A. Hassan
DOI: 10.1016/j.hrcr.2026.01.008
Cited by: 1
References: 8

Abstract

Leadless pacemaker (LP) implantation and its adoption are becoming increasingly mainstream1. The Abbott Aveir VR single-chamber pacemaker was approved for use in April 2022 by the FDA.2 As implantations increase, rare complications such as dislodgement of these pacemakers may occur. LPs are implanted percutaneously through femoral venous access and provide self-contained, intracardiac single-chamber right ventricular (RV) pacing. Device dislodgement rates of 1.7% were reported in the Leadless II trial at six months of follow up.

Fields of Study & Subjects

Cardiac pacing and defibrillation studies Cardiac Valve Diseases and Treatments Cardiac Structural Anomalies and Repair

Publication details

Journal / source
HeartRhythm Case Reports
Publisher
Elsevier BV
Volume
12
Issue
4
Pages
398–402
Publication date
23 January 2026
Language
EN